TCRX vs TFX · rev $2.0M vs P/E 2083, rev $1.12B
Tscan Therapeutics Inc (TCRX) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
TCRX currently screens at market cap $62.1M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the TCRX and TFX stock pages for the full models.
Not investment advice.